Aboniki Balm - Ultra Strength Topical Pain Relief Balm - White by J C UDEOZOR & SONS GLOBAL INDUSTRIES LTD

Aboniki Balm - Ultra Strength Topical Pain Relief Balm - White by

Drug Labeling and Warnings

Aboniki Balm - Ultra Strength Topical Pain Relief Balm - White by is a Otc medication manufactured, distributed, or labeled by J C UDEOZOR & SONS GLOBAL INDUSTRIES LTD. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ABONIKI BALM - ULTRA STRENGTH TOPICAL PAIN RELIEF BALM - WHITE- camphor, eucalyptus, menthol, methyl salicylate ointment 
J C UDEOZOR & SONS GLOBAL INDUSTRIES LTD

----------

Aboniki® Balm - Ultra Strength Topical Pain Relief Balm - White

Drug Facts

Drug Facts

Active Ingredients

Active Ingredients (In each gram)

Camphor 4%

Menthol 16%

Methyl Salicylate 49%

Purpose

Active Ingredients (In each gram) ​Purpose
Camphor 4%External Analgesic
Menthol 16%External Analgesic
Methyl Salicylate 49%External Analgesic

USES

Temporarily relieves minor aches & pains related to:

  • arthritis
  • simple backaches
  • sore muscles
  • joint pain
  • dislocation
  • leg cramps
  • bruises
  • sprains

Warning

For external use only.

Do not use

  • on wounds or damaged skin
  • with a heating pad
  • if you are allergic to any of the ingredients

Ask a doctor or pharmacist before use if you have

  • sensitive skin
  • redness over the affected area

When using this product

  • avoid contact with eyes and mucous membranes
  • do not bandage tightly

Stop use and ask a doctor if

  • rash, itching, or excessive irritation of the skin develops
  • condition worsens or symptoms persist for more than 7 days
  • symptoms clear up and occur again within a few days

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Direction

  • Use only as directed
  • For adults and children over 12 years, apply to the affected area 3 to 4 times daily
  • Wash hands after use
  • For Children under 12 years, consult a doctor before use

Other Information

  • Store in a cool, dry place between 20 oC to 25 oC (68 oF - 77 oF)
  • Do not use if the seal is broken
  • See cap for lot no, mfg, and exp date

Inactive Ingredients

Eucalyptus Oil, Lanolin, Microcrystalline Wax, Paraffin, Petrolatum.

Contact Info

Distributed by:

J. C. Udeozor & Sons Global Industries Limited

Email:

Info-US@aboniki.com

Mail:

300 Delaware Ave, Suite 210 #465
Wilmington, DE 19801

USA

Aboniki ® Balm - Ultra Strength Topical Pain Relief Balm - Twin Pack [Two 25g (0.88 OZ) Jar Inside]

  • Aboniki ® Balm - Ultra Strength Topical Pain Relief Balm - White
  • New Powerful Formula
  • Fast and Deep Penetrating Pain Relief

ABONIKI Ultra Strength - White 20230822

ABONIKI BALM - ULTRA STRENGTH TOPICAL PAIN RELIEF BALM - WHITE 
camphor, eucalyptus, menthol, methyl salicylate ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 82729-005
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL160 mg  in 1 g
METHYL SALICYLATE (UNII: LAV5U5022Y) (SALICYLIC ACID - UNII:O414PZ4LPZ) METHYL SALICYLATE490 mg  in 1 g
CAMPHOR (SYNTHETIC) (UNII: 5TJD82A1ET) (CAMPHOR (SYNTHETIC) - UNII:5TJD82A1ET) CAMPHOR (SYNTHETIC)40 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
EUCALYPTUS OIL (UNII: 2R04ONI662)  
MICROCRYSTALLINE WAX (UNII: XOF597Q3KY)  
PETROLATUM (UNII: 4T6H12BN9U)  
PARAFFIN (UNII: I9O0E3H2ZE)  
LANOLIN (UNII: 7EV65EAW6H)  
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorMENTHOLImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 82729-005-0125 g in 1 JAR; Type 0: Not a Combination Product10/02/2023
2NDC: 82729-005-022 in 1 CARTON10/02/2023
2NDC: 82729-005-0125 g in 1 JAR; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01710/02/202312/31/2024
Labeler - J C UDEOZOR & SONS GLOBAL INDUSTRIES LTD (851768299)

Revised: 1/2025
 
J C

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.